ExcepGen
Solving fundamental problems in drug discovery to create a new generation of therapeutics.
3 employees · est. 2018 · San Francisco, United States
ExcepGen is the older company (2021 vs 2018); Belharra Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Belharra Therapeutics | ExcepGen |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2018 older |
| Headquarters | ||
| Headquarters | San Diego, United States | San Francisco, United States |
| Employees | ||
| Employees | 40 larger | 3 |
| Industry | ||
| Industry | Not tracked yet | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Unknown | Seed |
| Total Funding | ||
| Total Funding | $50.00M | $4.18M |
| Funding Rounds | ||
| Funding Rounds | 2 | 3 |
| Services | ||
| Services | Searchlight Platform, Chemoproteomics Analysis, Novel Drug Target Identification | Development of RNA-based vaccines, Research on mRNA encoded proteins, Creating solutions to modify cellular responses, Production of nucleoside modifications |
| Target Customers | ||
| Target Customers | Biotechnology Researchers, Pharmaceutical Companies, Drug Development Organizations | Pharmaceutical companies, Biotech research institutions, Healthcare providers, Vaccine developers |
| Taxonomy | ||
| Taxonomy | Drug Discovery, Photoaffinity-based Chemoproteomics, Noncovalent Drug Discovery, Biotech Innovation, Small Molecule Drug Candidates, Protein Binding Sites, Transformative Medicines, Chemical Biology, Biotech Incubation, Biotech Startups, Scripps Research Collaboration, Versant Ventures, Inception Therapeutics, San Francisco Bay Area, San Diego Biotech | Drug Discovery, Therapeutics, Protein Research, Venture-backed, Early-stage Company, R&D, San Francisco-based, Biopharmaceuticals, Therapeutic Development, Scientific Research, Biotech Startup, Life Sciences, Diagnostic Technology |
| Website | ||
| Website | belharratx.com | excepgen.com |
About Belharra Therapeutics
Belharra Therapeutics, with the slogan "Redefining UnDruggable", is poised to reshape the landscape of drug discovery through its cutting-edge photoaffinity-based chemoproteomics platform. Founded in 2021, this privately held company has rapidly emerged as a disruptor, driven by a diverse team of bi...
About ExcepGen
ExcepGen, an early-stage biotechnology startup founded in 2018, is rapidly making its mark in the biopharma and healthcare sectors. Located in San Francisco, United States, the company is devoted to addressing fundamental challenges in drug discovery. With the ambitious slogan "Solving fundamental p...
We will tell you when either one moves
BounceWatch watches Belharra Therapeutics and ExcepGen for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Belharra Therapeutics and ExcepGen — by email.
Frequently Asked Questions
Compare Belharra Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Belharra Therapeutics on 9 Jun 2026, and ExcepGen on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.